Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined glenohumeral and subacromial sodium hyaluronate injection for partial rotator cuff injury
ChiCTR2500095547Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium hyaluronate in Rotator cuff deficiency (RCD) (2 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: VAS score at week 12. Started Jan 2025; status: recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR2500095547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095547.